Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine.
Kamen
B A
BA
Casper
J
J
Lauer
S
S
Camitta
B M
BM
Holcenberg
J S
JS
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000008:administration & dosage; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000473:pathology; D008727:Methotrexate / Q000008:administration & dosage; D013713:Teniposide / Q000008:administration & dosage
D003561:Cytarabine; D013713:Teniposide; D008727:Methotrexate